RxDoctor Payments DataLook up a doctor →

Veeral Sheth, MD

Ophthalmology · Oak Forest, ILNPI 1881806784

Payments from drug & device makers

$14,821,250in general payments, 2019–2025

Across 3,109 payments — averaging $4767.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$8.1M
  • Regeneron$2.9M
  • Novartis$914K
  • Ocular Therapeutix, Inc.$625K
  • Hexal AG$369K
  • Bayer$288K
  • plus $1.6M from 31 others
$49,296in research payments, 2019–2025

Across 41 payments — averaging $1202.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$49K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,821,250 in reported general payments places this provider in the 95th percentile of 773 ophthalmology providers in Illinois.

See all ophthalmology providers in Illinois

Medicare billing

Part B allowed, 2024
$2,199,792
Medicare patients
654
Services billed
39,191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Oak Forest

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →